Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FDK99
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $98,275
Award facts
- Contract value 100% obligated
- $98,274.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $98,274.72 by the Defense Logistics Agency (DLA) on August 8, 2025. The award covers the supply of Keytruda 100 mg/4 ml vials, an oncology therapeutic used in cancer treatment, with an ultimate completion date of August 29, 2025. This delivery order was issued under a firm fixed-price structure with no set-aside designation, leveraging the company's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499,999,999 vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities.
The Keytruda delivery order represents one of numerous pharmaceutical product orders DMS Pharmaceutical Group fulfills for the Department of Defense healthcare system, reflecting the company's established role as a critical supplier within the federal pharmaceutical supply chain. The DLA utilizes the SPE2DB program to support the medical supply needs of military treatment facilities nationwide through firm fixed-price delivery orders covering prescription medications, biologics, and specialty pharmaceutical products. DMS Pharmaceutical Group's performance under the parent indefinite delivery contract and its woman-owned small business status have positioned the vendor as a preferred federal contractor for oncology and specialty medication distribution to DoD healthcare facilities.
Quick answers
Who was awarded contract SPE2DB25FDK99?
SPE2DB25FDK99 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FDK99 worth?
The government has obligated $98,275 on SPE2DB25FDK99.
Is contract SPE2DB25FDK99 an order under another contract?
Yes. SPE2DB25FDK99 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDK99 competed?
The extent of competition for SPE2DB25FDK99 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award